Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11219644 Universal immune cells for cancer immunotherapy

Patent 11219644 was granted and assigned to Baylor College of Medicine on January, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 27 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12018080 Methods and compositions for treating cancer by targeting the CLEC2D-KLRB1 pathway
0
Edits on 13 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 13 Dec, 2023
Edits made to:
Article (+364 characters)
Article

Patent abstract

Embodiments of the disclosure encompass adoptive immunotherapy related to cells expressing multiple chimeric antigen receptors (CARs). In specific embodiments, T cells express a HER2-specific CAR, an IL13 Rα2-specific CAR, and an EphA2-specific CAR. In particular embodiments, the cells are utilized for cancer treatment, including for glioblastoma.

Edits on 23 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1121964400
Edits on 8 Apr, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 Apr, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11617767 Armed dual CAR-T compositions and methods for cancer immunotherapy
0
Edits on 28 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Baylor College of Medicine
Baylor College of Medicine
0
Current Assignee
Baylor College of Medicine
Baylor College of Medicine
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112196440
Date of Patent
January 11, 2022
0
Patent Application Number
155462590
Date Filed
January 26, 2016
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=112196440
Patent Primary Examiner
‌
James D Schultz
0
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Baylor College of Medicine
Baylor College of Medicine
0
Current Assignee
Baylor College of Medicine
Baylor College of Medicine
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112196440
Date of Patent
January 11, 2022
0
Patent Application Number
155462590
Date Filed
January 26, 2016
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=112196440
Patent Primary Examiner
‌
James D Schultz
0
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=11219644
Edits on 13 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 13 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 11219644 Universal immune cells for cancer immunotherapy

Infobox
Is a
Patent
Patent
Patent applicant
Baylor College of Medicine
Baylor College of Medicine
Current assignee
Baylor College of Medicine
Baylor College of Medicine
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11219644
Date of patent
January 11, 2022
Patent application number
15546259
Date Filed
January 26, 2016
Patent primary examiner
‌
James D Schultz

Find more entities like US Patent 11219644 Universal immune cells for cancer immunotherapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo